Tag archive for ‘US drug development company’
Yoel Bermant On Sunday, April 27th, 2014

Cambrex names Shlomo Yanai chairman

– – Former Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) CEO Shlomo Yanai has been appointed chairman of US drug development company Cambrex Corporation (NYSE: CBM). He succeeds More...

Wordpress site Developed by Fixing WordPress Problems